Suchergebnisse - "Mantle cell lymphoma"

PubPharm (3.552)

1

Clinical Management of Mantle Cell Lymphoma With Concurrent Vascular Complications : A Case Report

enthalten in: Cureus | 2024

von Athiraman, H. | Maheshwari, M.

2

Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma

enthalten in: Hematological oncology | 2024

von Feng, J. | Fei, Y. | Gao, M. | +10

3

Inhibition of Autophagy Augments the Anticancer Activity of KPT-330 in Mantle Cell Lymphoma Cells

enthalten in: Zhongguo shi yan xue ye xue za zhi | 2024

von Zhang, Y. | Chen, Y. | Zheng, R. | +1

4

Front-line and second-line treatment for mantle cell lymphoma in clinical practice : A multicenter retrospective analysis

enthalten in: European journal of haematology | 2024

von Harmanen, M. | Sorigue, M. | Khan, M. | +12

5

Anlotinib Inhibiting Mantle Cell Lymphoma Proliferation and Inducing Apoptosis through PI3K/AKT/mTOR Pathway

enthalten in: Current molecular medicine | 2024

von Wang, J. | Xu, Z. | Lai, Y. | +6

6

Management of relapsed/refractory mantle cell lymphoma

enthalten in: Leukemia & lymphoma | 2024

von Alzahrani, M. | Villa, D.

7

Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma : a multi-center real-life survey

enthalten in: Annals of hematology | 2024

von Duminuco, A. | Romano, A. | Ferrarini, I. | +10

8

Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma

enthalten in: Cell reports. Medicine | 2024

von Hoang, N. | Liu, Y. | Bates, P. | +12

9

Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor

enthalten in: Advances in therapy | 2024

von Salles, G. | Chen, J. | Zhang, I. | +12

10

Immunoglobulin High Throughput Sequencing (Ig-HTS) Minimal Residual Disease (MRD) Analysis is an Effective Surveillance Tool in Patients With Mantle Cell Lymphoma

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Rezazadeh, A. | Pruett, J. | Detzner, A. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[356]